Systemic Lupus Erythematosus Outpatients Medication Knowledge and Quality of Life

Maria Caecilia Nanny Setiawati, Nyoman Kertia, Ika Puspitaningrum


According to the Indonesian Lupus Foundation (YLI) in the last decade, the number of people with SLE (Systemic Lupus Erythematosus) has continued to increase every year. This research was undertaken to assess the medication knowledge and quality of life among SLE outpatients who had been counselled by pharmacist. A cross-sectional, non-experimental, descriptive study design was used in this research. A total of 121 respondents from Semarang and Yogyakarta met the criteria. Seventy (57,85%) respondents had previous counseling, while 51 (42,15%) respondents never. Their knowledge score was 32,17 ± 3,52 and the quality of life was 59,23 ± 17,04. There was any correlation between the knowledge score and their quality of life. *P 0,014. Their average age was 31,53 ± 7,77 years. It was positively related with their Quality of life *P 0,031 but not to their knowledge score. The participants’ education level and disease duration were not considerably related with QoL and knowledge. Previous counseling by the pharmacists was positively related to their knowledge score, but not to their quality of life (*P 0,034 and 0,793). The conclusion that can be drawn is the SLE outpatients had low knowledge and their quality of life is not good enough. Pharmacists’ counseling can improve SLE outpatients’ knowledge scores significantly but not their QoL.


Knowledge; outpatients; pharmacist counselling; QoL; SLE

Full Text:



Alkatheri, A. M., and Albekairy, A. M. (2013). Does the Patients’ Educational Level and Previous Counseling Affect their Medication Knowledge?. Annals of thoracic medicine, 8(2), 105.

Barbhaiya, M., and Costenbader, K. H. (2014). Ultraviolet Radiation and Systemic Lupus Erythematosus. Lupus, 23(6), 588-595.

Chen, H. J., Wang, H., Qiu, L. J., Ling, H. Y., Wu, L. L., Wang, T. R., Zhou, Y., Xue, Y., Ye, D. Q., and Wang, B. (2022). Relation Among Anxiety, Depression, Sleep Quality and Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus: Path Analysis. Patient Preference and Adherence, 1351-1358.

da Hora, T. C., Lima, K., and Maciel, R. R. B. T. (2019). The effect of Therapies on the Quality of Life of Patients with Systemic Lupus Erythematosus: A Meta-Analysis of Randomized Trials. Advances in Rheumatology, 59(1), 34.

Etchegaray-Morales, I., Méndez-Martínez, S., Jiménez-Hernández, C., Mendoza-Pinto, C., Alonso-García, N. E., Montiel-Jarquín, A., Lopez-Combo, A., Garcia-Villasensor, M. H., Cardiel, M., and García-Carrasco, M. (2017). Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol. PLoS One, 12(1),

García-Carrasco, M., Pinto, C. M., Hernández, C. J., Poblano, J. C. S., Morales, I. E., and Martínez, S. M. (2013). Antiphospholipid Syndrome. In Autoimmunity: From Bench to Bedside [Internet]. Bogota: El Rosario University Press.

Ganachari, M. S., and Almas, S. A. (2012). Evaluation of Clinical Pharmacist Mediated Education and Counselling of Systemic Lupus Erythematosus Patients in Tertiary Care Hospital. Indian Journal of Rheumatology, 7(1), 7-12.

Gomez, A., Qiu, V., Cederlund, A., Borg, A., Lindblom, J., Emamikia, S., .Enman, Y., Lampa, J and Parodis, I. (2021). Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus. Frontiers in Medicine, 8, 651249.

Grundy, V. (2006). The Pharmacist’s Role in the Treatment of Systemic Lupus Erythematosus. US Pharm, 5, 39-48.

Kasitanon, N., Wangkaew, S., Puntana, S., Sukitawut, W., Leong, K. P., Tan Tock Seng Hospital Lupus Study Group, and Louthrenoo, W. (2013). The Reliability, Validity and Responsiveness of the Thai Version of Systemic Lupus Erythematosus Quality of Life (SLEQOL-TH) instrument. Lupus, 22(3), 289-296.

Kementrian Kesehatan RI. (2016). Petunjuk Teknis Program Deteksi Dini Pengendalian Penyakit Lupus Eritematosus Sistemik di Fasilitas Kesehatan Tingkat Pertama. Jakarta: Ditjen Pelayanan Kesehatan.

Khanna, S., Pal, H., Pandey, R. M., and Handa, R. (2004). The Relationship between Disease Activity and Quality of Life In Systemic Lupus Erythematosus. Rheumatology, 43(12), 1536-1540.

Kuriya, B., Gladman, D. D., Ibañez, D., and Urowitz, M. B. (2008). Quality of Life Over Time in Patients with Systemic Lupus Erythematosus. Arthritis Care & Research, 59(2), 181-185.

Lins, L., and Carvalho, F. M. (2016). SF-36 Total Score as a Single Measure of Health-Related Quality of Life: Scoping review. SAGE open medicine, 4, 2050312116671725

Mcelhone, K., Abbott, J., and Teh, L. S. (2006). A Review of Health Related Quality of Life in Systemic Lupus Erythematosus. Lupus, 15(10), 633-643.

Olesińska, M., and Saletra, A. (2018). Quality of Life in Systemic Lupus Erythematosus and its Measurement. Reumatologia, 56(1), 45-54.

Permata, A., Perwitasari, D. A., Candradewi, S. F., and Prio, B. (2022). Penilaian Kualitas Hidup Pasien Kanker Nasofaring Dengan Menggunakan EORTC QLQ-C30 di RSUP dr. Kariadi Semarang. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 7(1), 39-47.

Pettersson, S., Lövgren, M., Eriksson, L. E., Moberg, C., Svenungsson, E., Gunnarsson, I., and Welin Henriksson, E. (2012). An Exploration of Patient-Reported Symptoms in Systemic Lupus Erythematosus and the Relationship to Health-Related Quality of Life. Scandinavian Journal of Rheumatology, 41(5), 383-390.

Riwidikdo, H. (2013). Statistika Kesehatan. Yogyakarta: Rohima Press.

Sanii, Y., Torkamandi, H., Gholami, K., Hadavand, N., and Javadi, M. (2016). Role of Pharmacist Counseling in Pharmacotherapy Quality Improvement. Journal of Research in Pharmacy Practice, 5(2), 132.

Schmitt, M. R., Miller, M. J., Harrison, D. L., Farmer, K. C., Allison, J. J., Cobaugh, D. J., and Saag, K. G. (2011). Communicating Non-Steroidal Anti-Inflammatory Drug Risks: Verbal Counseling, Written Medicine Information, and Patients’ Risk Awareness. Patient Education and Counseling, 83(3), 391-397.

Setiawati, M. C. N., Nyoman, K., Ikawati, Z., Melani, F., and Meika, W. N. (2014). Evaluasi Penggunaan Obat, Pengukuran Aktivitas Penyakit dan Pemberian Konseling Pasien Systemic Lupus Erythematosus (SLE). Media Farmasi Indonesia, 9(2).

Shahin, D. (2011). Thrombocytopenia and Leukocytosis are Independent Predictors of Hyperprolactinemia in Systemic Lupus Erythematosus Patients. The Egyptian Rheumatologist, 33(2), 77-83.

Slevin, M. L., Plant, H., Lynch, D. A., Drinkwater, J., and Gregory, W. M. (1988). Who Should Measure Quality of Life, The Doctor or The Patient?. British Journal of Cancer, 57(1), 109-112.

Waldheim, E. (2013). Self-reported pain in SLE. Sweden: Karolinska Institutet.

Wang, C. H. E. N. C. H. E. N., Mayo, N. E., and Fortin, P. R. (2001). The Relationship Between Health Related Quality of Life and Disease Activity and Damage in Systemic Lupus Erythematosus. The Journal of Rheumatology, 28(3), 525-532.


  • There are currently no refbacks.